Latest Blood Disorders news
WHO: Plasma Therapy for COVID-19 Still Experimental
posted August 25th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Wider Use of Plasma as COVID-19 Treatment
posted August 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Emergency Approval on Hold for Blood Plasma to Treat COVID-19
posted August 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
Convalescent Plasma Efficacious for Severe COVID-19
posted August 14th
by modernClinician Editorial Team
by modernClinician Editorial Team
.jpg)
Mortality Lowest at Hemoglobin Concentrations Above WHO Thresholds 
Oral Vitamin C Active in Clonal Cytopenia of Undetermined Significance 
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Ultra-Endurance Running Accelerates Red Blood Cell Aging Related Articles
Maternal Anemia, Erythrocytosis Linked to Neonatal Morbidity and Mortality 
Recommendations Developed for Diagnosing Light Chain Amyloidosis 
IV Iron Dextran Cost-Effective for Managing Iron-Deficiency Anemia 
Liberalized Diet Not a Safe Alternative to Neutropenic Diet in Adults Being Treated for Acute Leukemia Monthly Specialist Briefings
Stay Connected
